​

IQVIA (IQV) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

IQV Stock Forecast

IQVIA (IQV) stock forecast, based on 44 Wall Street analysts, predicts a 12-month average price target of $229.22, with a high of $258.00 and a low of $185.00. This represents a 41.25% increase from the last price of $162.28.

$160 $180 $200 $220 $240 $260 High: $258 Avg: $229.22 Low: $185 Last Closed Price: $162.28

IQV Stock Rating

IQVIA stock's rating consensus is Buy, based on 44 Wall Street analysts. The breakdown includes 1 Strong Buy (2.27%), 36 Buy (81.82%), 6 Hold (13.64%), 1 Sell (2.27%), and 0 Strong Sell (0.00%).

Buy
Total 44 1 6 36 1 Strong Sell Sell Hold Buy Strong Buy

IQV Price Target Upside V Benchmarks

TypeNameUpside
StockIQVIA41.25%
SectorHealthcare Stocks 15.45%
IndustryDiagnostics & Research Stocks32.15%
IdeaSaaS Stocks List35.63%

Price Target Trends

1M3M12M
# Anlaysts1925
Avg Price Target$185.00$225.56$231.20
Last Closing Price$162.28$162.28$162.28
Upside/Downside14.00%38.99%42.47%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 264173--24
Mar, 264165--25
Feb, 263165--24
Jan, 263165--24
Dec, 253165--24
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 08, 2026Elizabeth AndersonEvercore ISI$185.00$172.547.22%14.00%
Feb 23, 2026Mizuho Securities$215.00$165.6229.82%32.49%
Feb 19, 2026Truist Financial$245.00$165.6447.91%50.97%
Feb 11, 2026Morgan Stanley$240.00$178.8834.17%47.89%
Feb 06, 2026UBS$240.00$184.0130.43%47.89%
Feb 06, 2026BMO Capital$250.00$184.7535.32%54.05%
Feb 06, 2026Stifel Nicolaus$220.00$184.6719.13%35.57%
Feb 06, 2026Luke SergottBarclays$210.00$180.9616.05%29.41%
Feb 05, 2026Elizabeth AndersonEvercore ISI$225.00$180.9624.34%38.65%
Jan 09, 2026Mizuho Securities$266.00$243.199.38%63.91%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Apr 08, 2026Evercore ISIOutperformOutperformhold
Mar 06, 2026BarclaysOverweightOverweightupgrade
Feb 05, 2026Evercore ISIOutperformOutperformhold
Jan 22, 2026Cowen & Co.HoldHoldhold
Jan 08, 2026UBSBuyBuyhold
Nov 03, 2025Cowen & Co.BuyHolddowngrade
Oct 29, 2025UBSBuyBuyhold
Oct 29, 2025CitigroupNeutralNeutralhold
Oct 09, 2025HSBCHoldBuyupgrade
Oct 08, 2025Evercore ISIOutperformOutperformhold

Financial Forecast

EPS Forecast

$5 $8 $11 $14 $17 $20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$5.05$5.82$7.39$7.57$7.91---
Avg Forecast$8.91$10.15$10.19$11.12$11.92$13.28$14.73$16.44
High Forecast$9.08$10.36$10.21$11.17$12.16$15.49$16.25$16.73
Low Forecast$8.79$9.99$10.17$11.10$11.61$11.72$12.58$15.94
Surprise %-43.32%-42.66%-27.48%-31.92%-33.64%---

Revenue Forecast

$14B $15B $16B $17B $19B $20B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$13.87B$14.41B$14.98B$15.40B$16.31B---
Avg Forecast$13.83B$14.38B$14.91B$15.38B$16.04B$17.01B$18.04B$19.49B
High Forecast$14.02B$14.61B$14.92B$15.39B$16.21B$17.01B$18.06B$19.76B
Low Forecast$13.68B$14.21B$14.90B$15.35B$15.68B$17.01B$18.02B$19.03B
Surprise %0.32%0.20%0.49%0.18%1.71%---

Net Income Forecast

$500M $1B $2B $2B $3B $4B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$966.00M$1.09B$1.36B$1.37B$1.36B---
Avg Forecast$896.18M$1.17B$1.36B$2.07B$2.21B$2.54B$2.69B$3.06B
High Forecast$1.08B$1.41B$1.63B$2.08B$2.27B$2.89B$3.03B$3.12B
Low Forecast$716.94M$938.68M$1.09B$2.07B$2.16B$2.18B$2.34B$2.97B
Surprise %7.79%-7.02%--33.80%-38.57%---

IQV Forecast FAQ

Is IQVIA stock a buy?

IQVIA stock has a consensus rating of Buy, based on 44 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 36 Buy, 6 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that IQVIA is a favorable investment for most analysts.

What is IQVIA's price target?

IQVIA's price target, set by 44 Wall Street analysts, averages $229.22 over the next 12 months. The price target range spans from $185 at the low end to $258 at the high end, suggesting a potential 41.25% change from the previous closing price of $162.28.

How does IQVIA stock forecast compare to its benchmarks?

IQVIA's stock forecast shows a 41.25% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the diagnostics & research stocks industry (32.15%), leading the saas stocks list (35.63%) investment idea.

What is the breakdown of analyst ratings for IQVIA over the past three months?

  • April 2026: 16.67% Strong Buy, 70.83% Buy, 12.50% Hold, 0% Sell, 0% Strong Sell.
  • March 2026: 16.00% Strong Buy, 64.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 12.50% Strong Buy, 66.67% Buy, 20.83% Hold, 0% Sell, 0% Strong Sell.

What is IQVIA’s EPS forecast?

IQVIA's average annual EPS forecast for its fiscal year ending in December 2026 is $13.28, marking a 67.89% increase from the reported $7.91 in 2025. Estimates for the following years are $14.73 in 2027, and $16.44 in 2028.

What is IQVIA’s revenue forecast?

IQVIA's average annual revenue forecast for its fiscal year ending in December 2026 is $17.01B, reflecting a 4.30% increase from the reported $16.31B in 2025. The forecast for 2027 is $18.04B, and $19.49B for 2028.

What is IQVIA’s net income forecast?

IQVIA's net income forecast for the fiscal year ending in December 2026 stands at $2.54B, representing an 86.43% increase from the reported $1.36B in 2025. Projections indicate $2.69B in 2027, and $3.06B in 2028.